Viatris Inc.: Rhinitis, Allergic trials

The registry lists 25 Rhinitis, Allergic studies with Viatris Inc. as lead sponsor. 0 are open to participants now and 16 have results posted.

Phase 1 3Phase 2 1Phase 3 16Phase 4 4No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Dymista Allergen Chamber - Onset of Action StudyCompletedNCT04652245Phase 4Results posted
• Safety and Efficacy Trial of Dymista Nasal Spray in Children Ages 4 to 11 With Seasonal Allergic Rhinitis (SAR)CompletedNCT01915823Phase 3Results posted
• Safety of Astepro 0.15% Nasal Spray and Astepro 0.1% Nasal Spray in Children Ages >6 Months to <6 Years With ARCompletedNCT01880840Phase 4Results posted
• 3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic RhinitisCompletedNCT01794741Phase 3Results posted
• A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic RhinitisCompletedNCT01018862Phase 3Results posted
• A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal AllergiesCompletedNCT00883168Phase 3Results posted
• A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal AllergiesCompletedNCT00824473Phase 3Results posted
• Study to Evaluate the Safety and Tolerability of a Nasal Spray in Patients With Chronic Allergic or Nonallergic RhinitisCompletedNCT00783432Phase 3Results posted
• A Study Evaluating the Safety and Effectiveness of a Nasal Spray to Treat Seasonal AllergiesCompletedNCT00740792Phase 3Results posted
• A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic RhinitisCompletedNCT00720382Phase 3Results posted
• A Study to Evaluate the Safety and Efficacy of Two Nasal Sprays to Treat Seasonal AllergiesCompletedNCT00720278Phase 3Results posted
• A Study to Evaluate the Safety & Effectiveness of a Nasal Spray to Treat Seasonal AllergiesCompletedNCT00719862Phase 3Results posted
• A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial AllergiesCompletedNCT00712920Phase 3Results posted
• A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal AllergiesCompletedNCT00660829Phase 3Results posted
• A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal AllergiesCompletedNCT00660517Phase 3Results posted
• A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal AllergiesCompletedNCT00651118Phase 3Results posted
• Dymista in Chinese AdolescentsActive, not recruitingNCT07597473Phase 4
• Azelastine Allergen Chamber - Onset of Action StudyCompletedNCT06126952Phase 2
• Observational Study to Evaluate the Actual Use and Effectiveness of Dymista® Nasal Spray in Asian PatientsCompletedNCT05158972
• DYmista NAsal Spray in CHInese PatientsCompletedNCT03599791Phase 3
• MP-AzeFlu Allergen Chamber - Onset of Action StudyCompletedNCT03004131Phase 4
• A Comparison of Mometasone Nasal Spray, Nasonex Nasal Spray, Nasonex Nasal Spray Suspension, & Placebo for Treatment of Seasonal Allergies for Safety, Efficacy, & Superiority in 1520 Male & Female VolunteersCompletedNCT02109185Phase 1
• A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Seasonal AllergiesCompletedNCT01368445Phase 3
• Single Dose Pharmacokinetics of Intranasal Fluticasone Delivered by a Fixed Combination With Azelastine (MP29 02) in Comparison to Two Different Fluticasone Nasal SpraysCompletedNCT01194622Phase 1
• Single Dose Pharmacokinetics of Intranasal Azelastine Delivered by a Fixed Combination With Fluticasone in Comparison to Azelastine Nasal SpraysCompletedNCT01190852Phase 1